Nutrition in Neonatal Pulmonary Disease

  • Janice Cox
Part of the Nutrition and Health book series (NH)


This chapter provides an overview of the most common pulmonary conditions encountered in the newborn infant population for which there are nutritional implications, the goals of nutrition management, and evidence-based interventions to achieve these goals. The pulmonary diseases and conditions covered in this chapter include neonatal respiratory distress syndrome (RDS), transient tachypnea of the newborn (TTNB), meconium aspiration syndrome (MAS), bronchopulmonary dysplasia (BPD), and chylothorax.


Prematurity Later preterm infant Low birth weight Respiratory distress syndrome Transient tachypnea of the newborn Meconium aspiration syndrome Bronchopulmonary dysplasia Chylothorax 


  1. 1.
    Landry JS, Menzies D. Occurrence and severity of bronchopulmonary dysplasia and respiratory distress syndrome after preterm birth. Paediatr Child Health. 2011;16:399–403.PubMedGoogle Scholar
  2. 2.
    Horbar JD, Carpenter JH, Badger GJ, et al. Mortality and neonatal morbidity among infants 501 to 1500 grams form 2000 to 2009. Pediatrics. 2012;129:1019–26.PubMedGoogle Scholar
  3. 3.
    Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network. Pediatrics. 2010;126:443–56.PubMedGoogle Scholar
  4. 4.
    Colin AA, McEvoy C, Castile RG. Respiratory morbidity and lung function in preterm infants of 32 to 36 weeks’ gestational age. Pediatrics. 2010;126:115–28.PubMedGoogle Scholar
  5. 5.
    Kotecha S. Lung growth: implications for the newborn infant. Arch Dis Child Fetal Neonatal Ed. 2000;82:F69–74.PubMedGoogle Scholar
  6. 6.
    Sweet D, Bevilacqua G, Carnielli V, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome. J Perinat Med. 2007;35:175–86.PubMedGoogle Scholar
  7. 7.
    McIntyre DD, Leveno KJ. Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol. 2008;111:35–41.Google Scholar
  8. 8.
    Bird TM, Bronstein JM, Hall RW, et al. Late preterm infants: birth outcomes and health care utilization in the first year. Pediatrics. 2010;126:e311–9.PubMedGoogle Scholar
  9. 9.
    Engle WA, Tomachek KM, Wallman C, The Committee on Fetus and Newborn. “Late-preterm” infants: a population at risk. Pediatrics. 2007;120:1390–401.PubMedGoogle Scholar
  10. 10.
    Swarnam K, Soraisham AS, Sivanandan S. Advances in the management of meconium aspiration syndrome. Int J Pediatr. 2012;2012(3595171):1–7.Google Scholar
  11. 11.
    Kalenga M, Tschanz SA, Burri PH. Protien deficiency and the growing rat lung: I. Nutritional findings and related lung volumes. Pedatr Res. 1995;37:783–8.Google Scholar
  12. 12.
    Lipsett J, Tamblyn M, Madigan K, et al. Restricted fetal growth and lung development: a morphometric analysis of pulmonary structure. Pediatr Pulmonol. 2006;41:1138–45.PubMedGoogle Scholar
  13. 13.
    Mataloun MMGB, Leone CR, Mascaretti RS, et al. Effect of postnatal malnutrition on hyperoxia-induced newborn lung development. Braz J Med Biol Res. 2009;42:606–13.PubMedGoogle Scholar
  14. 14.
    Ehrenkranz RA, Das A, Wrage LA, Poindexter BB, Higgins RD, Stoll BJ, Oh W. Early nutrition mediates the influence of severity of illness on extremely low birth weight infants. Pediatr Res. 2011;69:522–9.PubMedGoogle Scholar
  15. 15.
    Radmacher PG, Rafail ST, Adamkin DH. Nutrition and growth in very-very-low-birth-weight infants with and without bronchopulmonary dysplasia. Neonatal Intensive Care. 2004;16:22–6.Google Scholar
  16. 16.
    Horowitz K, Feldman D, Stuart B, et al. Full-term neonatal intensive care unit admission in an urban community hospital: the role of respiratory morbidity. J Matern Fetal Neonatal Med. 2011;24:1407–10.PubMedGoogle Scholar
  17. 17.
    Jaksic T, Hull MA, Modi BP, et al. A.S.P.E.N. clinical guidelines: nutrition support of neonates supported with extracorporeal membrane oxygenation. JPEN J Parenter Enteral Nutr. 2010;34:247–53.PubMedGoogle Scholar
  18. 18.
    Northway Jr WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med. 1967;276:357–68.PubMedGoogle Scholar
  19. 19.
    Van Marter LJ. Progress in discovery and evaluation of treatments to prevent bronchopulmonary dysplasia. Biol Neonate. 2006;89:303–12.PubMedGoogle Scholar
  20. 20.
    Pfister RH, Goldsmith JP. Quality improvement in respiratory care: decreasing bronchopulmonary dysplasia. Clin Perinatol. 2012;37:273–93.Google Scholar
  21. 21.
    Philip AG. Bronchopulmonary dysplasia: then and now. Neonatology. 2012;102:1–8.PubMedGoogle Scholar
  22. 22.
    Jobe AH, Bancalari E. Bronchopulmonary dysplasia. NICHD/NHLBI/ORD workshop summary. Am J Respir Crit Care Med. 2001;163:1723–9.PubMedGoogle Scholar
  23. 23.
    Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007;196:147.e1–8.Google Scholar
  24. 24.
    Lemons JA, Oh W, Korones SB, et al. Very low birthweight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 to December 1996. Pediatrics. 2001;107:e1–6.PubMedGoogle Scholar
  25. 25.
    Ruegger C, Hegglin M, Adams M, et al. Population based trends in mortality, morbidity and treatment for very preterm and very low birth weight infants over 12 years. BMC Pediatr. 2012;12:17–28.PubMedGoogle Scholar
  26. 26.
    Caserio S, Gallego C, Martin P, et al. Congenital chylothorax: from foetal life to adolescence. Acta Paediatr. 2010;99:1571–7.PubMedGoogle Scholar
  27. 27.
    Carey BE. Neonatal chylothorax. Neonatal Netw. 2001;20:53–5.PubMedGoogle Scholar
  28. 28.
    Chan GM, Lechtenberg E. The use of fat-free human milk in infants with chylous pleural effusion. J Perinatol. 2007;27:434–6.PubMedGoogle Scholar
  29. 29.
    Winnie GB, Lossef SV. Chapter 409, Chylothorax. In: Kliegman RM, Stanton BMD, St. Geme J, et al., editors. Nelson textbook of pediatrics. 19th ed. Philadelphia, PA: Elsevier Saunders; 2011.Google Scholar
  30. 30.
    Cleveland K, Zook D, Harvey K, et al. Massive chylothorax in small babies. J Pediatr Surg. 2009;44:546–50.PubMedGoogle Scholar
  31. 31.
    Lawrence RA, Lawrence RM. Breastfeeding: a guide for the medical profession. 7th ed. St. Louis, MO: Mosby; 2011. p. 102–7.Google Scholar
  32. 32.
    Meijer PP, Engstrom JL, Jegier BJ. Improving the use of human milk during and after the NICU stay. Clin Perinatol. 2007;37:217–45.Google Scholar
  33. 33.
    Carlson SJ. Parenteral nutrition. In: Groh-Wargo S, Thompson M, Cox JH, editors. American dietetic association pocket guide to neonatal nutrition. Chicago, IL: American Dietetic Association; 2009. p. 29–63.Google Scholar
  34. 34.
    Vanek VW, Borum P, Buchman A, et al. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. Nutr Clin Pract. 2012;27:440–91.PubMedGoogle Scholar
  35. 35.
    Oh W, Poindexter BB, Perritt R, et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr. 2005;147:786–90.PubMedGoogle Scholar
  36. 36.
    Stroustrup A, Trasande L, Holzman IR. Randomized controlled trial of restrictive fluid management in transient tachypnea of the newborn. J Pediatr. 2012;160:38–43.PubMedGoogle Scholar
  37. 37.
    Darlow BA, Graham PJ. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birth weight infants. Cochrane Database Syst Rev. 2011;(10):CD000501.Google Scholar
  38. 38.
    Agostoni C, Buonocore G, Carnielli VP, et al. Enteral nutrient supply for preterm infants: commentary from the European society for paediatric gastroenterology, hepatology, and nutrition committee on nutrition. J Pediatr Gastroenterol Nutr. 2010;50:1–9.Google Scholar
  39. 39.
    Klein CJ. (editor). Life sciences research office report: nutrient requirements for preterm infant formulas. J Nutr. 2002;132:1395S–577S.Google Scholar
  40. 40.
    Lawrence RA, Lawrence RM. Appendix A. Composition of human milk. In: Breastfeeding: a guide for the medical profession. Maryland Heights, MO: Mosby; 2011. p. 740–1.Google Scholar
  41. 41.
    Senterre T, Rigo J. Reduction in postnatal cumulative nutritional deficit and improvement of growth in extremely preterm infants. Acta Paediatr. 2012;101:e64–70.PubMedGoogle Scholar
  42. 42.
    Ziegler EE. Protein requirements of very low birth weight infants. J Pediatr Gastroenterol Nutr. 2007;45:S170–4.PubMedGoogle Scholar
  43. 43.
    Reifen RM, Zlotkin S. Ch 13 Microminerals. In: Tsang RC, Lucas A, Uauy R, Zlotkin S, editors. Nutritional needs of the preterm infant: scientific basis and practical guidelines. Pawling, NY: Caduceus Medical Publishers, Inc.; 1993. p. 201.Google Scholar
  44. 44.
    Fomon SJ. Protein. Nutrition of normal infants. St. Louis, MO: Mosby-Yearbook, Inc.; 1993. p. 137.Google Scholar
  45. 45.
    Institute of Medicine. Dietary reference intakes (DRIs): recommended dietary allowances and adequate intakes, elements, and total water and macronutrients. Food and Nutrition Board, Institute of Medicine, National Academies. Accessed 12 Aug 2012.
  46. 46.
    Raiten DJ, Talbot JM, Waters JH. (editors). Life sciences research office report: executive summary for the report: assessment of nutrient requirements for formulas. J Nutr. 1998;128:2059S–294S.Google Scholar
  47. 47.
    Moyer-Mileur LJ. Anthropometry and laboratory assessment of very low birth weight infants: the most helpful measurements and why. Semin Perinatol. 2007;31:96–103.PubMedGoogle Scholar
  48. 48.
    Moyer-Mileur LJ, Thompson M. Nutrition assessment. In: Groh-Wargo S, Thompson M, Cox JH, editors. ADA pocket to neonatal nutrition. Chicago, IL: American Dietetic Association; 2009. p. 1–28.Google Scholar
  49. 49.
    Fenton TR. A new growth chart for preterm babies: Babson and Benda’s updated with recent data and a new format. BMC Pediatr. 2003;1:3–13.Google Scholar
  50. 50.
    WHO Child Growth Standards. Accessed 12 Jan 2012.
  51. 51.
    Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:200–8.PubMedGoogle Scholar
  52. 52.
    Denne SC. Regulation of proteolysis and optimal protein accretion in extremely premature newborns. Am J Clin Nutr. 2007;85:621S–4.PubMedGoogle Scholar
  53. 53.
    Embleton ND. Optimal protein and energy intakes in preterm infants. Early Hum Dev. 2007;83:831–7.PubMedGoogle Scholar
  54. 54.
    Lai NM, Rajadurai SV, Tan KH. Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/chronic lung disease. Cochrane Database Syst Rev. 2006;(3):CD005093.Google Scholar
  55. 55.
    Bassiouny MR, Almarsafawy H, Abdel-Hady H, et al. A randomized controlled trial on parenteral nutrition, oxidative stress and chronic lung diseases in preterm infants. J Pediatr Gastroenterol Nutr. 2009;48:363–9.PubMedGoogle Scholar
  56. 56.
    Chessex P, Watson C, Kaczala GW, et al. Determinants of oxidant stress in extremely low birth weight premature infants. Free Radic Biol Med. 2010;49:1380–6.PubMedGoogle Scholar
  57. 57.
    Laborie S, Lovoie J-C, Pineault M, Chessex P. Protecting solutions of parenteral nutrition from peroxidation. JPEN J Parenter Enteral Nutr. 1999;23:104–8.PubMedGoogle Scholar
  58. 58.
    Lavoie PM, Lavoie JC, Watson C, et al. Inflammatory response in preterm infants is induced early in life by oxygen and modulated by total parenteral nutrition. Pediatr Res. 2010;68:248–51.PubMedGoogle Scholar
  59. 59.
    Shew SB, Keshen TH, Jahoor F, Jaksic T. The determinants of protein catabolism in neonates on extracorporeal membrane oxygenation. J Pediatr Surg. 1999;34:1086–90.PubMedGoogle Scholar
  60. 60.
    Buck ML, Wooldridge P, Ksenich RA. Comparison of methods for intravenous infusion of fat emulsion during extracorporeal membrane oxygenation. Pharmacotherapy. 2005;25:1536–40.PubMedGoogle Scholar
  61. 61.
    Kavvadia V, Greenough A, Dimitriou G, et al. Randomised trial of fluid restriction in ventilated very low birth weight infants. Arch Dis Child Fetal Neonatal Ed. 2000;83:F91–6.PubMedGoogle Scholar
  62. 62.
    Theile AR, Radmacher PG, Anschutz TW, et al. Nutritional strategies and growth in extremely low birth weight infants with bronchopulmonary dysplasia over the past 10 years. J Perinatol. 2012;32:117–22.PubMedGoogle Scholar
  63. 63.
    de Meer K, Westerterp K, Houwen RH, et al. Total energy expenditure in infants with bronchopulmonary dysplasia is associated with respiratory status. Eur J Pediatr. 1997;156:299–304.PubMedGoogle Scholar
  64. 64.
    Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics. 2009;123:1562–73.PubMedGoogle Scholar
  65. 65.
    Bier JA, Ferguson A, Cho C, et al. The oral motor development of low-birth-weight infants who underwent orotracheal intubation during the neonatal period. Am J Dis Child. 1993;147:858–62.PubMedGoogle Scholar
  66. 66.
    Hicks PD, Rogers SP, Hawthorne KM, et al. Calcium absorption in very low birth weight infants with and without bronchopulmonary dysplasia. J Pediatr. 2011;158:885–90.PubMedGoogle Scholar
  67. 67.
    Brunton JA, Saigal S, Atkinson SA. Growth and body composition in infants with bronchopulmonary dysplasia up to 3 months corrected age: a randomized trial of a high-energy nutrient-enriched formula fed after hospital discharge. J Pediatr. 1998;133:340–5.PubMedGoogle Scholar
  68. 68.
    Skinner AM, Battin M, Solimano A, et al. Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia. Am J Perinatol. 1997;14:539–46.PubMedGoogle Scholar
  69. 69.
    Tropea K, Christou H. Current pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia. Int J Pediatr. 2012;Article ID 598606:9.Google Scholar
  70. 70.
    Ramanathan R. Bronchopulmonary dysplasia and diuretics. NeoReviews. 2008;9:e260–7.Google Scholar
  71. 71.
    Giapros VI, Papadimitriou FK, Andronikou SK. Tubular disorders in low birth weight neonates after prolonged antibiotic treatment. Neonatology. 2007;91:140–4.PubMedGoogle Scholar
  72. 72.
    Fernandez Alvarez JR, Kalache KD, Grauel EL. Management of spontaneous congenital chylothorax: oral medium chain triglycerides versus total parenteral nutrition. Am J Perinatol. 1999;16:415–20.PubMedGoogle Scholar
  73. 73.
    Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2008;1, CD000503.PubMedGoogle Scholar
  74. 74.
    Bhatia J. Fluid and electrolyte management in the very low birth weight neonate. J Perinatol. 2006;26:S19–21.PubMedGoogle Scholar
  75. 75.
    Tsang RC, Uauy R, Koletzko B, Zlotkin SH, editors. Nutrition of the preterm infant scientific bases and practical guidelines. 2nd ed. Cincinnati, OH: Digital Education Publishing; 2005.Google Scholar
  76. 76.
    Baumgart S, Costarino AT. Water and electrolyte metabolism of the micropremie. Clin Perinatol. 2000;27:131–46.PubMedGoogle Scholar
  77. 77.
    Poindexter BB, Langer JC, Dusick AM, et al. Early provision of parenteral amino acids in extremely low birth weight infants: relation to growth and neurodevelopmental outcome. J Pediatr. 2006;148:300–5.PubMedGoogle Scholar
  78. 78.
    Senterre T, Rigo J. Optimizing early nutritional support based on recent recommendations in VLBW infants and postnatal growth restriction. J Pediatr Gastroenterol Nutr. 2011;53:536–42.PubMedGoogle Scholar
  79. 79.
    Balakrishnan M, Tucker R, Stephens BE, et al. Blood urea nitrogen and serum bicarbonate in extremely low birth weight infants receiving higher protein intake in the first week after birth. J Perinatol. 2011;31:535–9.PubMedGoogle Scholar
  80. 80.
    Frank K, Sosenko IR. Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia. Am Rev Respir Dis. 1988;138:725–9.PubMedGoogle Scholar
  81. 81.
    Sosensko IR, Frank L. Nutritional influences on lung development and protection against chronic lung disease. Semin Perinatol. 1991;15:462–8.Google Scholar
  82. 82.
    Toffolo A, Trevisanuto D, Meneghetti S, et al. Non-furosemide-related renal calcification in premature infants with bronchopulmonary dysplasia. Acta Paediatr Jpn. 1997;39:433–6.PubMedGoogle Scholar
  83. 83.
    Ehrenkranz RA, Dusick AM, Vohr BR, et al. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics. 2006;117:1253–61.PubMedGoogle Scholar
  84. 84.
    Spears K, Cheney C, Zerzan J. Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long term respiratory disability in very-low-birth-weight infants. Am J Clin Nutr. 2004;80:1589–94.PubMedGoogle Scholar
  85. 85.
    Atkinson SA. Special nutritional needs of infants for prevention of and recovery from bronchopulmonary dysplasia. J Nutr. 2001;131:942S–6.PubMedGoogle Scholar
  86. 86.
    Wardle SP, Hughes A, Chen S, Shaw NJ. Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 2001;84:F9–13.PubMedGoogle Scholar
  87. 87.
    Ambalavanan N, Wu TJ, Tyson JE, et al. A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants. J Pediatr. 2003;142:656–61.PubMedGoogle Scholar
  88. 88.
    Fomon SJ, Bell EF. Chapter 21 Vitamin E. In: Fomon SJ, editor. Nutrition of normal infants. St. Louis, MO: Mosby-Year Book, Inc.; 1993. p. 339–47.Google Scholar
  89. 89.
    Brion LP, Bell EF, Raghuveer TS, Darlow BA, Austin NC. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2003;(4):CD003665.Google Scholar
  90. 90.
    Mostafa-Gharehbaghi M, Mostafa-Gharabaghi P, Ghanbari F, et al. Determination of selenium in serum samples of preterm newborn infants with bronchopulmonary dysplasia using a validated hydride generation system. Biol Trace Elem Res. 2012;147:1–7.PubMedGoogle Scholar
  91. 91.
    Mayo Clinic, Mayo Medical Laboratories. Accessed 12 Dec 2012.
  92. 92.
    Darlow BA, Austin NC. Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane Database Syst Rev. 2003;4, CD003312.PubMedGoogle Scholar
  93. 93.
    Hallman M, Arjomaa P, Hoppu K. Inositol supplementation in respiratory distress syndrome: relationship between serum concentration, renal excretion, and lung effluent phospholipids. J Pediatr. 1987;110:604–10.PubMedGoogle Scholar
  94. 94.
    Hallman M, Bry K, Hoppu K, et al. Inositol supplementation in premature infants with respiratory distress syndrome. N Engl J Med. 1992;325:1233–9.Google Scholar
  95. 95.
    Hallman M, Jarvenpaa A-L, Pohjavuori M. Respiratory distress syndrome and inositol supplementation in preterm infants. Arch Dis Child. 1986;61:1076–83.PubMedGoogle Scholar
  96. 96.
    Pereira GR, Baker L, Egler J, et al. Serum myoinositol concentrations in premature infants fed human milk, formula for infants, and parenteral nutrition. Am J Clin Nutr. 1990;51:589–93.PubMedGoogle Scholar
  97. 97.
    Ogasa K, Kuboyama M, Kiyosawa I, et al. The content of free and bound inositol in human and cow’s milk. J Nutr Sci Vitaminol (Tokyo). 1975;21:129–35.Google Scholar
  98. 98.
    Carver JD, Stromquist CI, Benford VJ, et al. Postnatal inositol levels in preterm infants. J Perinatol. 1997;17:389–92.PubMedGoogle Scholar
  99. 99.
    Keshen TH, Miller RG, Jahoor F, Jaksic T. Stable isotopic quantitation of protein metabolism and energy expenditure in neonates on- and post-extracorporeal life support. J Pediatr Surg. 1977;32:958–62.Google Scholar
  100. 100.
    Jadcherla SR, Berseth CL. Antroduodenal motility and feeding outcome among neonatal extracorporeal membrane oxygenation survivors. J Pediatr Gastroenterol Nutr. 2005;41:347–50.PubMedGoogle Scholar
  101. 101.
    Huysman WA, de Ridder M, de Bruin NC, et al. Growth and body composition in preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed. 2003;88:F46–51.PubMedGoogle Scholar
  102. 102.
    McLeod G, Simmer K, Benniger H, et al. Preterm infant with chronic lung disease: are protein and energy intakes after discharge sufficient for optimal growth? J Paediatr Child Health. 2011;47:127–33.PubMedGoogle Scholar
  103. 103.
    Madden J, Kobaly K, Minich NM, et al. Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia. J Perinatol. 2010;30:103–11.PubMedGoogle Scholar
  104. 104.
    deReignier RO, Guilbert TW, Mills MM, Georgieff MK. Growth failure and altered body composition are established by one month of age in infants with bronchopulmonary dysplasia. J Nutr. 1996;126:168–75.Google Scholar
  105. 105.
    Stephens BE, Walden RV, Gargus RA, et al. First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics. 2009;123:1337–43.PubMedGoogle Scholar
  106. 106.
    Casey PH, Whiteside-Mansell L, Barrett K, et al. Impact of prenatal and/or postnatal growth problems in low birth weight preterm infants on school-age outcomes: an 8-year longitudinal evaluation. Pediatrics. 2006;118:1078–86.PubMedGoogle Scholar
  107. 107.
    McCormick FM, Henderson G, Fahey T, McGuire W. Multinutrient fortification of human breast milk for preterm infants following hospital discharge. Cochrane Database Syst Rev. 2012;7, CD004866.Google Scholar
  108. 108.
    Koo WK, Hockman EM. Posthospital discharge feeding for preterm infants: effects of standard compared with enriched milk formula on growth, bone mass, and body composition. Am J Clin Nutr. 2006;84:1357–64.PubMedGoogle Scholar
  109. 109.
    Puangco MA, Schanler RJ. Clinical experience in enteral nutrition support for premature infants with bronchopulmonary dysplasia. J Perinatol. 2000;2:87–91.Google Scholar
  110. 110.
    Mizuno K, Nishida Y, Taki M, et al. Infants with bronchopulmonary dysplasia suckle with weal pressures to maintain breathing during feeding. Pediatrics. 2007;120:e1035–42.PubMedGoogle Scholar
  111. 111.
    Wang L-Y, Luo H-J, Hsieh W-S, et al. Severity of bronchopulmonary dysplasia and increased risk of feeding desaturation and growth delay in very low birth weight preterm infants. Pediatr Pulmonol. 2010;45:165–73.PubMedGoogle Scholar
  112. 112.
    Cox JH, Thompson M, Groh-Wargo S. Medical/surgical conditions: respiratory disease. In: Groh-Wargo S, Thompson M, Cox JH, editors. American dietetic association pocket guide to neonatal nutrition. Chicago, IL: American Dietetic Association; 2009. p. 108.Google Scholar
  113. 113.
    Gupta S, Prasanth K, Chen C-M, Yeh TF. Postnatal corticosteroids for prevention and treatment of chronic lung disease in preterm newborn. Int J Pediatr. 2012;article ID315642:12.Google Scholar
  114. 114.
    Van Goudoever JB, Wattimena JD, Carnielli VP, et al. Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia. J Pediatr. 1994;124:112–8.PubMedGoogle Scholar
  115. 115.
    Murphy KE, Willan AR, Hannah ME, et al. Effect of antenatal corticosteroids on fetal growth and gestational age at birth. Obstet Gynecol. 2012;119:917–23.PubMedGoogle Scholar
  116. 116.
    Fomon SJ. Nutrition of normal infants. St. Louis, MO: Mosby-Year Book, Inc.; 1993. p. 410.Google Scholar
  117. 117.
    Guthrie HA, Picciano MF, Sheehe D. Fatty acid patterns of human milk. J Pediatr. 1977;90:39–41.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2014

Authors and Affiliations

  1. 1.SchoolcraftUSA

Personalised recommendations